enow.com Web Search

  1. Ads

    related to: new cholesterol medication without statins treatment cost based on prescription

Search results

  1. Results from the WOW.Com Content Network
  2. Alirocumab - Wikipedia

    en.wikipedia.org/wiki/Alirocumab

    Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors , and it was the first such agent ...

  3. An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds.. When taken as a daily pill, bempedoic acid ...

  4. Does Medicare cover Repatha, and what does it cost? - AOL

    www.aol.com/lifestyle/does-medicare-cover...

    People can hand the copay card to a pharmacist when picking up their prescription to reduce the cost further. Without insurance, people may pay more than $600 per month for Repatha. Read more ...

  5. Evolocumab - Wikipedia

    en.wikipedia.org/wiki/Evolocumab

    Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) .

  6. In two studies, experimental drugs for cholesterol show ...

    www.aol.com/news/two-studies-experimental-drugs...

    Both medications target people born with a genetic predisposition to high cholesterol. While drugs like statins , as well as diet and exercise, can help these individuals manage cholesterol, they ...

  7. Inclisiran - Wikipedia

    en.wikipedia.org/wiki/Inclisiran

    Inclisiran, sold under the brand name Leqvio, is a medication used for the treatment of high low-density lipoprotein (LDL) cholesterol and for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH).

  1. Ads

    related to: new cholesterol medication without statins treatment cost based on prescription